A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Public ClinicalTrials.gov record NCT02283957. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study 4975-MN-202 is a double-blind, placebo-controlled, parallel group, single-injection study in which subjects will be randomized to receive three doses of CNTX-4975 or placebo injected into the intermetatarsal space around a Morton's neuroma. The injection of study medication will be administered by ultrasound-guided needle placement following ankle block anesthesia. The study staff will telephone subjects at Week 1 postinjection and subjects will return to the clinic postinjection at Weeks 2, 4, 8, and 12 for study assessments.
Study identification
- NCT ID
- NCT02283957
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 119 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Type not available)
- Primary completion
- Aug 2015 (Actual)
- Completion
- Jun 2016 (Actual)
- Last update posted
- Dec 6, 2016
2014 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Premier Research | Phoenix | Arizona | 85027 | — |
| NEA Baptist Clinic | Jonesboro | Arkansas | 72410 | — |
| Center for Clinical Research, Inc | Castro Valley | California | 94546 | — |
| eStudySite, La Mesa | La Mesa | California | 91942 | — |
| TriWest Research Associates | La Mesa | California | 91942 | — |
| Chesapeake Research Group, LLC | Pasadena | Maryland | 21122 | — |
| Center for Advanced Medicine and Research | City of Saint Peters | Missouri | 63303 | — |
| University Orthopedics Center- Altoona | Altoona | Pennsylvania | 16602 | — |
| University Orthopedics Center | State College | Pennsylvania | 16801 | — |
| Allcare Foot and Ankle Center | Arlington | Texas | 76011 | — |
| Premier Research | Austin | Texas | 78728 | — |
| Endeavor Clinical Trials, PA | San Antonio | Texas | 78229 | — |
| Wasatch Clinical Research, LLC | Salt Lake City | Utah | 84107 | — |
| Jean Brown Research | Salt Lake City | Utah | 84124 | — |
| The Education and Research Foundation | Lynchberg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02283957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02283957 live on ClinicalTrials.gov.